W N Charman

发表

Transport and absorption of drugs via the lymphatic system.

C. Porter, W. Charman, C J Porter, 2001, Advanced drug delivery reviews.

In vitro assessment of oral lipid based formulations.

C. Porter, W. Charman, C J Porter, 2001, Advanced drug delivery reviews.

Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH.

J. Dressman, C. Porter, W. Charman, 1997, Journal of pharmaceutical sciences.

Simultaneous continuous recording of accommodation and pupil size using the modified Shin‐Nippon SRW‐5000 autorefractor

J S Wolffsohn, B Gilmartin, B. Gilmartin, 2004, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.

Intestinal lymphatic drug transport: an update.

C. Porter, W. Charman, C J Porter, 2001, Advanced drug delivery reviews.

Animal models for the study of intestinal lymphatic drug transport.

G. Edwards, C. Porter, W. Charman, 2001, Advanced drug delivery reviews.

A physicochemical basis for the effect of food on the absolute oral bioavailability of halofantrine.

C. Porter, W. Charman, C J Porter, 1996, Journal of pharmaceutical sciences.

Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats.

C. Porter, W. Charman, C J Porter, 2000, Journal of pharmaceutical sciences.

Effect of Food and a Monoglyceride Emulsion Formulation on Danazol Bioavailability

M. Rogge, W. Charman, W N Charman, 1993, Journal of clinical pharmacology.

Association of halofantrine with postprandially derived plasma lipoproteins decreases its clearance relative to administration in the fasted state.

G. Edwards, C. Porter, W. Charman, 1998, Journal of pharmaceutical sciences.

The formulation of Halofantrine as either non-solubilizing PEG 6000 or solubilizing lipid based solid dispersions: physical stability and absolute bioavailability assessment.

C. Porter, W. Charman, S. Khoo, 2000, International journal of pharmaceutics.

LIPID-BASED FORMULATIONS FOR ORAL ADMINISTRATION: OPPORTUNITIES FOR BIOAVAILABILITY ENHANCEMENT AND LIPOPROTEIN TARGETING OF LIPOPHILIC DRUGS

C. Porter, W. Charman, C J Porter, 2001, Journal of receptor and signal transduction research.

Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts.

W. Charman, W N Charman, 2000, Journal of pharmaceutical sciences.